Loading
institutionsInstitution
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences
China's national blood disease hospital in Tianjin is where the CD19 binder behind the CAR-T inati-cel was made; it runs large leukaemia and myelodysplastic syndrome registries and early-phase trials of domestic bispecifics and cell therapies.
Also called: Blood Diseases Hospital CAMS中国医学科学院血液病医院IH-CAMS
Overview
The national centre for haematology within CAMS, with the State Key Laboratory of Experimental Hematology; origin of the CNCT19 CAR-T (inaticabtagene autoleucel, approved 2023 for adult B-ALL with Juventas), large leukaemia and myelodysplastic syndrome registries and early-phase trials of domestic bispecifics and cell therapies.
Location
Tianjin, CN
Type
hospital · Chinese Academy of Medical Sciences and Peking Union Medical College
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
OnCo score
#418 · 12 points (0 Newsweek + 0 NCI + 12 from 6 linked objects) · ranking
Research output
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-09-24.
Matched to Chinese Academy of Medical Sciences & Peking Union Medical College, including child institutions. 4,969 works · 62,764 citations · 73% open access · 10% clinical trials · 3% reviews.
Oncology works per year
1,0032022
1,0692023
9992024
1,1412025
7572026
Most works
- Binghe Xu81 works
- Fei Ma70 works
- Xishan Wang64 works
- Jie Wang62 works
- Jianxiang Wang54 works
- Jianqiang Tang41 works
- Zhijie Wang39 works
- Jie He39 works
- Shiwen Mei38 works
- Nan Bi36 works
Most cited
- State Key Laboratory of Experimental Hematology
- CAR-T development
- Leukaemia registries and trials
Similar pages
- CompanyJuventas Cell Therapy
Shares Inaticabtagene autoleucel, CAR-T cell therapy, Acute lymphoblastic leukaemia and the tag china.
- InstitutionPeking University People's Hospital
Shares CAR-T cell therapy, Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tag china.
- PersonXiaojun Huang
Shares Acute lymphoblastic leukaemia, Acute myeloid leukaemia and the tag china.
- TrialDAWNA-1
Shares Cancer Hospital, Chinese Academy of Medical Sciences and the tag china.
- InstitutionNational Cancer Center of China
Shares Cancer Hospital, Chinese Academy of Medical Sciences and the tag china.
- CompanyIASO Biotherapeutics
Shares CAR-T cell therapy and the tag china.
- PersonSaijuan Chen
Shares Acute myeloid leukaemia and the tag china.
- InstitutionRenji Hospital, Shanghai Jiao Tong University
Shares CAR-T cell therapy and the tag china.
cancers
technologies
drugs
ApprovedCell therapy (autologous CD19 CAR-T)
Inaticabtagene autoleucel · Yuanruida